Lynx1 Capital Management LP CCCC Holdings History
Lynx1 Capital Management LP's C4 Therapeutics Inc Holding Summary
As of 2025-03-31, Lynx1 Capital Management LP held 7.10 Mil shares of C4 Therapeutics Inc(CCCC), totaling $11.36 Mil. This investment constitutes 4.07% of their stock portfolio, and Lynx1 Capital Management LP now holds 10% of the outstanding C4 Therapeutics Inc(CCCC) stock.
The initial trade took place in 2023Q3. And since then Lynx1 Capital Management LP has made 5 purchases of CCCC, at an average price of $4.47, for a total of 7.13 Mil shares. In addition, there have been 1 sales at an average price of $4.96 for 27,783.00 shares. Based on historical transaction data and CCCC's current price of $2.42, Lynx1 Capital Management LP's estimated gain on his CCCC holdings is $-14.57 Mil, reflecting a -45.69% gain to date.
Lynx1 Capital Management LP CCCC ($2.42) Holding Chart
Lynx1 Capital Management LP CCCC ($2.42) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
